PMGC Holdings Inc ELAB Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$2.77 down $0.27, 8.88% at close Oct 16
Last close · Previous close $3.04
- Market cap
- At the Oct 16 close
- P/E ratio
- PausedOn last 12 months’ EPS
See the note under the price. - Diluted EPS
- PausedLast 12 months
See the note under the price. - Dividend yield
- NoneLast 12 months
Price chart
$2.77down $0.27, 8.88%Fri, Oct 16 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$3.04Oct 15
- Volume12.55KOct 16 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume52.82KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $2.59 to $1,771.18; now $2.77
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Oct 16 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
ELAB trailed the S&P 500 in all 4 periods.
| Period | ELAB and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | ELAB: down 41.9% S&P 500: up 1.5% | ELAB trailed the S&P 500 by 43.4 percentage points Trailed |
| 3M | ELAB: down 74.6% S&P 500: up 1.9% | ELAB trailed the S&P 500 by 76.5 percentage points Trailed |
| YTD | ELAB: down 99.2% S&P 500: up 12.8% | ELAB trailed the S&P 500 by 112.0 percentage points Trailed |
| 1Y | ELAB: down 99.9% S&P 500: up 16.8% | ELAB trailed the S&P 500 by 116.7 percentage points Trailed |
$10,000 invested in ELAB a year ago (Oct 16, 2025) would be worth about $15 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $11,678.
ELAB trailed the S&P 500 in all 4 periods.
| Period | ELAB and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | ELAB: down 41.9% S&P 500: up 1.2% | ELAB trailed the S&P 500 by 43.1 percentage points Trailed |
| 3M | ELAB: down 74.6% S&P 500: up 1.7% | ELAB trailed the S&P 500 by 76.3 percentage points Trailed |
| YTD | ELAB: down 99.2% S&P 500: up 11.9% | ELAB trailed the S&P 500 by 111.1 percentage points Trailed |
| 1Y | ELAB: down 99.9% S&P 500: up 15.5% | ELAB trailed the S&P 500 by 115.4 percentage points Trailed |
$10,000 invested in ELAB a year ago (Oct 16, 2025) would be worth about $15 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $11,553.
All-time high
$4,762,947.37
Closing high on . Now 100.0% below that record.
Split-adjusted daily closes since Nov 21, 2023.
Stock splits
6
Latest: 1-for-10 on . Share counts adjust after each split.
All 6 splits
- 1-for-10
- 1-for-6
- 1-for-4
- 2-for-7
- 1-for-7
- 1-for-200
Valuation
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $2.58M
- Net income
- −$13.49M
- Diluted EPS
- PausedSee the note under the price.
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q3 FY24 (Sep 30, 2024) | $0.00 | −$1.50M | Paused See the note under the price. |
| Q4 FY24 (Dec 31, 2024) | $0.00 | −$1.93M | Paused See the note under the price. |
| Q1 FY25 (Mar 31, 2025) | $0.00 | −$1.61M | Paused See the note under the price. |
| Q2 FY25 (Jun 30, 2025) | $0.00 | −$562.36K | Paused See the note under the price. |
| Q3 FY25 (Sep 30, 2025) | $285.95K | −$2.59M | Paused See the note under the price. |
| Q4 FY25 (Dec 31, 2025) | $304.14K | −$2.98M | Paused See the note under the price. |
| Q1 FY26 (Mar 31, 2026) | $681.99K | −$4.97M | Paused See the note under the price. |
| Q2 FY26 (Jun 30, 2026) | $1.31M | −$2.94M | Paused See the note under the price. |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $827.00 | −$784.74K | Paused See the note under the price. |
| FY22 (Dec 31, 2022) | $766.28K | −$1.80M | Paused See the note under the price. |
| FY23 (Dec 31, 2023) | $0.00 | −$4.30M | Paused See the note under the price. |
| FY24 (Dec 31, 2024) | $0.00 | −$6.25M | Paused See the note under the price. |
| FY25 (Dec 31, 2025) | $590.08K | −$7.75M | Paused See the note under the price. |
Margins
- Gross 31.1%
- Operating −458.6%
- Net −523.0%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- −$8.99MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow−$8.21MLast 12 months
- Capital spending$777.77KLast 12 months
- −348.4%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $23.74MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$0.00Last 12 months
- Total returned$0.00Last 12 months
Balance sheet
- $18.79MAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$14.24MAs of Jun 30, 2026
- Net cash$4.55MAs of Jun 30, 2026
- Book value per sharePausedAs of Jun 30, 2026
See the note under the price. - 1.36As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.85As of Jun 30, 2026
Total debt divided by shareholders’ equity on the Jun 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- −118.1%Last 12 months
Over the last 12 months, PMGC Holdings lost money: its net loss was 118.1% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - −59.7%Last 12 months
Over the last 12 months, PMGC Holdings’s net loss was 59.7% of its total assets (averaged over the last four quarter-ends).
ROA = Net income (last 12 months) ÷ Average total assets
About PMGC Holdings Inc
PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. Currently, our portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. We are committed to exploring opportunities in multiple sectors to maximize growth and value.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- California, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
ELAB news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
ELAB stock FAQ
What is ELAB stock’s price today?
PMGC Holdings (ELAB) traded at $2.77 at the close on , down $0.27 (8.88%) from the previous close of $3.04. Over the past 52 weeks it has traded between $2.59 and $1,771.18.
How much revenue does PMGC Holdings make?
PMGC Holdings reported $2.6 million of revenue over the four quarters to . In its latest quarter (Q2 FY26, ended ) revenue was $1.3 million.
Is PMGC Holdings profitable?
Not over the four quarters to . PMGC Holdings reported a net loss of $13.5 million across those four quarters on $2.6 million of revenue.
Does ELAB pay a dividend?
PMGC Holdings hasn’t paid a dividend in the last twelve months.
What is ELAB’s 52-week high and low?
Over the past 52 weeks ELAB has traded as low as $2.59 and as high as $1,771.18. At $2.77 at the close on , it is 99.8% below that high and 7.2% above the low.
What is ELAB’s all-time high?
ELAB’s highest closing price was $4,762,947.37 on , adjusted for stock splits. At $2.77 at the close on , it is 100.0% below that record.
Has ELAB stock ever split?
Yes, six times: 1-for-200 on ; 1-for-7 on ; 2-for-7 on ; 1-for-4 on ; 1-for-6 on ; 1-for-10 on .
How has ELAB stock performed?
Including dividends and measured to the close on , ELAB has returned −99.2% so far this year and −99.9% over the past year. Over the same periods the S&P 500, measured by SPY, returned +12.8% and +16.8%. Past performance doesn’t predict future returns.
What sector and industry is PMGC Holdings in?
PMGC Holdings is in the Healthcare sector and the Biotechnology industry, and is headquartered in California, USA.
What exchange does ELAB trade on?
PMGC Holdings trades on the Nasdaq under the ticker symbol ELAB. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.